
Keywords: فوربل dibutyrate; AGEs; advanced glycation end-products; VEGF; vascular endothelial growth factor; T2DM; type 2 diabetes mellitus; MTT; [3-(4,5-dimethylthiazol-2-yl)-2,5-diphenyltetrazolium bromide; PDB; phorbol dibutyrate; PKC; protein kinase C; DG; diacylglycerol; Aqueou